Ditchcarbon
  • Contact
  1. Organizations
  2. Genovac GmbH
Public Profile
Pharmaceutical Preparation Manufacturing
DE
updated a month ago

Genovac GmbH Sustainability Profile

Company website

Genovac GmbH, headquartered in Germany, is a leading player in the biotechnology industry, specialising in the development and production of high-quality nucleic acids and proteins. Founded in 2001, the company has established itself as a trusted partner for research institutions and pharmaceutical companies across Europe and beyond. With a focus on custom oligonucleotides, plasmid DNA, and RNA products, Genovac stands out for its commitment to precision and quality. The company’s state-of-the-art facilities and innovative technologies enable it to deliver tailored solutions that meet the specific needs of its clients. Recognised for its expertise and reliability, Genovac GmbH continues to strengthen its market position, contributing significantly to advancements in genetic research and therapeutic development.

DitchCarbon Score

How does Genovac GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Genovac GmbH's score of 20 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.

15%

Let us know if this data was useful to you

Genovac GmbH's reported carbon emissions

Genovac GmbH, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established documented reduction targets or commitments to climate initiatives such as the Science Based Targets initiative (SBTi) or other industry-standard frameworks. Without available emissions data or defined climate commitments, it is unclear how Genovac GmbH is addressing its carbon footprint or contributing to climate action within its industry. The lack of transparency in emissions reporting may reflect a broader trend in the sector, where many companies are still developing their sustainability strategies. As the company moves forward, establishing clear climate commitments and reduction targets will be essential for aligning with global climate goals and enhancing its environmental accountability.

How Carbon Intensive is Genovac GmbH's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Genovac GmbH's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Genovac GmbH's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Genovac GmbH is in DE, which has a medium grid carbon intensity relative to other regions.

Genovac GmbH's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Genovac GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Genovac GmbH's Emissions with Industry Peers

Celerion Inc.

US
•
Health and social work services (85)
Updated 19 days ago

Wuxi Apptec

CN
•
Research and development services (73)
Updated 7 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Intrexon Bioinformatics Germany GmbH

DE
•
Computer and related services (72)
Updated about 2 months ago

Boehringer Ingelheim Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Genscript Biotech Corporation

CN
•
Research and development services (73)
Updated 19 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251120.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy